Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2020-2026

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells.
Fujifilm Holding Corporation (CDI) was the global largest Players in Induced Pluripotent Stem Cells (iPSCs) industry,with the market share of 39% in 2018,followed by Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL.
Market Analysis and Insights: Global Induced Pluripotent Stem Cells (iPSCs) Market
In 2019, the global Induced Pluripotent Stem Cells (iPSCs) market size was US$ 82 million and it is expected to reach US$ 184.4 million by the end of 2026, with a CAGR of 12.2% during 2021-2026.
Global Induced Pluripotent Stem Cells (iPSCs) Scope and Market Size
Induced Pluripotent Stem Cells (iPSCs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells (iPSCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Induced Pluripotent Stem Cells (iPSCs) market is segmented into Human iPSCs, Mouse iPSCs, etc.
Segment by Application, the Induced Pluripotent Stem Cells (iPSCs) market is segmented into Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, etc.
Regional and Country-level Analysis
The Induced Pluripotent Stem Cells (iPSCs) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Induced Pluripotent Stem Cells (iPSCs) market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Induced Pluripotent Stem Cells (iPSCs) Market Share Analysis
Induced Pluripotent Stem Cells (iPSCs) market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Induced Pluripotent Stem Cells (iPSCs) business, the date to enter into the Induced Pluripotent Stem Cells (iPSCs) market, Induced Pluripotent Stem Cells (iPSCs) product introduction, recent developments, etc.
The major vendors include Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL, etc.

This report focuses on the global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL

Market segment by Type, the product can be split into

Human iPSCs
Mouse iPSCs
Human iPSCs had a market share of 89% in 2018, followed by Mouse iPSCs.

Market segment by Application, split into

Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Induced Pluripotent Stem Cells (iPSCs) status, future forecast, growth opportunity, key market and key players.
To present the Induced Pluripotent Stem Cells (iPSCs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Induced Pluripotent Stem Cells (iPSCs) are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.